Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SYMPHONY.NS Stock Summary
Top 10 Correlated ETFs
SYMPHONY.NS
In the News
SYMPHONY.NS Financial details
Company Rating
Neutral
Market Cap
57.12B
Income
1.15B
Revenue
11.32B
Book val./share
-
Cash/share
-
Dividend
4
Dividend %
0.44%
Employees
462
Optionable
No
Shortable
Yes
Earnings
03 May 2024
P/E
55.09
Forward P/E
14.04
PEG
-189.51
P/S
5.39
P/B
9.22
P/C
-
P/FCF
-
Quick Ratio
0.93
Current Ratio
1.38
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
16.7
EPS next Y
59.19
EPS next Q
-
EPS this Y
-3.14%
EPS next Y
254.45%
EPS next 5Y
254.45%
EPS last 5Y
4.78%
Revenue last 5Y
7.14%
Revenue Q/Q
-10.18%
EPS Q/Q
16.8%
-
-
-
-
SMA20
-7.56%
SMA50
-5.85%
SMA100
0.18%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
29%
ROC
0.18%
Gross Margin
45%
Oper. Margin
12%
Profit Margin
10%
Payout
-
Shs Outstand
68.96M
Shs Float
15.94M
-
-
-
-
Target Price
-
52W Range
821.25-1165.4
52W High
-28.67%
52W Low
+1.22%
RSI
26.8
Rel Volume
0.19
Avg Volume
104.34K
Volume
20.11K
Perf Week
-5.89%
Perf Month
-11.98%
Perf Quarter
-5.25%
Perf Half Y
-8.05%
-
-
-
-
Beta
0.388
-
-
Volatility
17.18%, 34.29%
Prev Close
-0.16%
Price
831
Change
-0.41%
SYMPHONY.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 120.28 | 157.27 | 128.26 | 147.94 | 169.16 | |
Net income per share | 13.19 | 25.94 | 15.34 | 17.2 | 16.58 | |
Operating cash flow per share | 19.95 | 22.43 | 12.67 | 8.12 | 17.8 | |
Free cash flow per share | 18.25 | 19.63 | 9.86 | 6.8 | 16.23 | |
Cash per share | 42.56 | 45.58 | 51.37 | 46.21 | 39.87 | |
Book value per share | 95.21 | 91.37 | 108.53 | 120 | 125.45 | |
Tangible book value per share | 74.57 | 65.84 | 78.28 | 89.61 | 95.4 | |
Share holders equity per share | 95.21 | 91.37 | 108.53 | 120 | 125.45 | |
Interest debt per share | 27.84 | 31.58 | 32.8 | 37.65 | 34.46 | |
Market cap | 95.86B | 54.48B | 88.49B | 76.81B | 71.22B | |
Enterprise value | 97.48B | 56.38B | 90.34B | 78.72B | 73B | |
P/E ratio | 103.89 | 30.02 | 82.44 | 63.84 | 61.18 | |
Price to sales ratio | 11.39 | 4.95 | 9.86 | 7.42 | 6 | |
POCF ratio | 68.68 | 34.72 | 99.81 | 135.13 | 56.98 | |
PFCF ratio | 75.09 | 39.67 | 128.27 | 161.39 | 62.48 | |
P/B Ratio | 14.39 | 8.52 | 11.66 | 9.15 | 8.08 | |
PTB ratio | 14.39 | 8.52 | 11.66 | 9.15 | 8.08 | |
EV to sales | 11.59 | 5.12 | 10.07 | 7.61 | 6.14 | |
Enterprise value over EBITDA | 59.75 | 22.49 | 59.14 | 44.29 | 38.83 | |
EV to operating cash flow | 69.84 | 35.93 | 101.89 | 138.49 | 58.4 | |
EV to free cash flow | 76.35 | 41.05 | 130.94 | 165.4 | 64.04 | |
Earnings yield | 0.01 | 0.03 | 0.01 | 0.02 | 0.02 | |
Free cash flow yield | 0.01 | 0.03 | 0.01 | 0.01 | 0.02 | |
Debt to equity | 0.28 | 0.33 | 0.29 | 0.3 | 0.26 | |
Debt to assets | 0.18 | 0.2 | 0.18 | 0.19 | 0.17 | |
Net debt to EBITDA | 0.99 | 0.76 | 1.21 | 1.07 | 0.95 | |
Current ratio | 2.32 | 2.05 | 2.53 | 2.3 | 1.81 | |
Interest coverage | 22.18 | 21.49 | 12.26 | 17.21 | 16.2 | |
Income quality | 1.52 | 0.86 | 0.83 | 0.47 | 1.08 | |
Dividend Yield | 0 | 0.03 | 0 | 0.01 | 0.01 | |
Payout ratio | 0.34 | 0.94 | 0.07 | 0.41 | 0.6 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | |
Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Intangibles to total assets | 0.14 | 0.17 | 0.18 | 0.16 | 0.15 | |
Capex to operating cash flow | -0.09 | -0.12 | -0.22 | -0.16 | -0.09 | |
Capex to revenue | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | |
Capex to depreciation | -1.21 | -0.93 | -0.92 | -0.38 | -0.42 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 168.09 | 230.92 | 193.56 | 215.48 | 216.31 | |
ROIC | 0.13 | 0.2 | 0.11 | 0.1 | 0.11 | |
Return on tangible assets | 0.1 | 0.21 | 0.11 | 0.1 | 0.1 | |
Graham Net | 14.27 | 7 | 13.1 | 15.1 | -4.41 | |
Working capital | 3.49B | 3.21B | 4.19B | 4.72B | 3.22B | |
Tangible asset value | 5.22B | 4.61B | 5.48B | 6.27B | 6.7B | |
Net current asset value | 2.13B | 2.05B | 2.37B | 3.13B | 1.99B | |
Invested capital | 0.28 | 0.33 | 0.29 | 0.3 | 0.26 | |
Average receivables | 1.58B | 1.57B | 1.47B | 2.31B | 2.03B | |
Average payables | 937.19M | 1.22B | 1.22B | 1.4B | 1.58B | |
Average inventory | 995.3M | 1.19B | 1.18B | 1.46B | 2.12B | |
Days sales outstanding | 82.98 | 40.68 | 69.83 | 102.56 | 35.64 | |
Days payables outstanding | 103.93 | 71.62 | 95.52 | 95.41 | 90.84 | |
Days of inventory on hand | 96.2 | 73.68 | 86.84 | 110.65 | 136.81 | |
Receivables turnover | 4.4 | 8.97 | 5.23 | 3.56 | 10.24 | |
Payables turnover | 3.51 | 5.1 | 3.82 | 3.83 | 4.02 | |
Inventory turnover | 3.79 | 4.95 | 4.2 | 3.3 | 2.67 | |
ROE | 0.14 | 0.28 | 0.14 | 0.14 | 0.13 | |
Capex per share | -1.7 | -2.8 | -2.81 | -1.32 | -1.57 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 39.14 | 44.85 | 43.29 | 39.76 | 35.6 | |
Net income per share | 5.51 | 2.25 | 3.44 | 5.06 | 5.91 | |
Operating cash flow per share | 1.98 | 2.04 | 2.01 | 2.02 | 1.73 | |
Free cash flow per share | 1.98 | 2.04 | 2.01 | 2.02 | 1.73 | |
Cash per share | 80.67 | 40.77 | 38.8 | 57.39 | 0 | |
Book value per share | 117.12 | 128.28 | 126.26 | 98.45 | 0 | |
Tangible book value per share | 0 | 97.56 | 0 | 68.67 | 0 | |
Share holders equity per share | 117.12 | 128.28 | 126.26 | 98.45 | 0 | |
Interest debt per share | 0.42 | 34.22 | 0.43 | 27.32 | 0.43 | |
Market cap | 64.05B | 69.65B | 62.61B | 60.87B | 60.97B | |
Enterprise value | 69.76B | 71.43B | 65.32B | 62.48B | 60.97B | |
P/E ratio | 41.06 | 112.92 | 65.22 | 43.48 | 37.18 | |
Price to sales ratio | 23.12 | 22.61 | 20.73 | 22.13 | 24.68 | |
POCF ratio | 457.49 | 497.5 | 447.21 | 434.76 | 508.08 | |
PFCF ratio | 457.49 | 497.5 | 447.21 | 434.76 | 508.08 | |
P/B Ratio | 7.73 | 7.91 | 7.11 | 8.94 | 0 | |
PTB ratio | 7.73 | 7.91 | 7.11 | 8.94 | 0 | |
EV to sales | 25.18 | 23.19 | 21.63 | 22.72 | 24.68 | |
Enterprise value over EBITDA | 120.27 | 216.45 | 155.51 | 120.15 | 103.34 | |
EV to operating cash flow | 498.28 | 510.21 | 466.54 | 446.26 | 508.08 | |
EV to free cash flow | 498.28 | 510.21 | 466.54 | 446.26 | 508.08 | |
Earnings yield | 0.01 | 0 | 0 | 0.01 | 0.01 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0.26 | 0 | 0.27 | 0 | |
Debt to assets | 0 | 0.17 | 0 | 0.15 | 0 | |
Net debt to EBITDA | 9.84 | 5.39 | 6.45 | 3.1 | 0 | |
Current ratio | 0 | 1.81 | 0 | 1.38 | 0 | |
Interest coverage | 12.33 | 8.67 | 11.67 | 22.5 | 17.67 | |
Income quality | 0.36 | 0.91 | 0.58 | 0.4 | 0.29 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.03 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.15 | 0 | 0.16 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 120.5 | 80.5 | 98.86 | 105.87 | 0 | |
ROIC | 0.04 | 0.02 | 0.03 | 0.04 | 0 | |
Return on tangible assets | 0 | 0.01 | 0 | 0.03 | 0 | |
Graham Net | 80.67 | -4.51 | 38.8 | -8.42 | 0 | |
Working capital | 5.71B | 3.22B | 2.71B | 1.85B | 0 | |
Tangible asset value | 0 | 6.7B | 0 | 4.75B | 0 | |
Net current asset value | 5.71B | 1.99B | 2.71B | 870M | 0 | |
Invested capital | 0 | 0.26 | 0 | 0.27 | 0 | |
Average receivables | 305M | 580M | 580M | 275M | 275M | |
Average payables | 610M | 830M | 830M | 785M | 785M | |
Average inventory | 740M | 1.25B | 1.25B | 855M | 855M | |
Days sales outstanding | 0 | 33.9 | 0 | 18 | 0 | |
Days payables outstanding | 0 | 82.54 | 0 | 95.47 | 0 | |
Days of inventory on hand | 0 | 124.31 | 0 | 103.99 | 0 | |
Receivables turnover | 0 | 2.66 | 0 | 5 | 0 | |
Payables turnover | 0 | 1.09 | 0 | 0.94 | 0 | |
Inventory turnover | 0 | 0.72 | 0 | 0.87 | 0 | |
ROE | 0.05 | 0.02 | 0.03 | 0.05 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
SYMPHONY.NS Frequently Asked Questions
What is Symphony Limited stock symbol ?
Symphony Limited is a IN stock and trading under the symbol SYMPHONY.NS
What is Symphony Limited stock quote today ?
Symphony Limited stock price is $831 today.
Is Symphony Limited stock public?
Yes, Symphony Limited is a publicly traded company.